Details
November 4, 2021
5:45PM - 8:00PM
Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications
Part 1
A Virtual Event
Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies.
The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases.
Part 1 Topics Include
- Explain terminology NGS, molecular testing, what does it exactly mean, how much tissue do you need?
- Dhananjay Chitale, MD, MBA
Henry Ford Hospital
- Understanding the report. What resources do physicians have to get further information on the test? Reporting test results with the patient.
- Christine Lovly, MD, PhD
Vanderbilt-Ingram Cancer Center
- Tumor Board Case Session
- Thoracic
- Igor Rybkin, MD, PhD
Henry Ford Cancer Institute / Henry Ford Health System
- GI
- Philip Philip, MD, PhD, FRCP
Karmanos Cancer Institute
Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Elements and Policies of the Michigan State Medical Society through the joint sponsorship of Munson Healthcare and the Michigan Society of Hematology and Oncology. Munson Healthcare is accredited by the Michigan State Medical Society to provide continuing medical education for physicians.
Munson Healthcare designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Be sure to also register for Part 2 of this series on November 16!
Printer-Friendly Version
Add to Calendar
aCLuDhaqizCaPxAftmqF167204
11/04/2021 05:45 PM
11/04/2021 08:00 PM
false
Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications
Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies.
The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases.
Part 1 Topics Include
Explain terminology NGS, molecular testing, what does it exactly mean, how much tissue do you need?
Dhananjay Chitale, MD, MBAHenry Ford Hospital
Understanding the report. What resources do physicians have to get further information on the test? Reporting test results with the patient.
Christine Lovly, MD, PhDVanderbilt-Ingram Cancer Center
Tumor Board Case Session
Thoracic
Igor Rybkin, MD, PhDHenry Ford Cancer Institute / Henry Ford Health System
GI
Philip Philip, MD, PhD, FRCPKarmanos Cancer Institute
Continuing EducationThis activity has been planned and implemented in accordance with the Accreditation Elements and Policies of the Michigan State Medical Society through the joint sponsorship of Munson Healthcare and the Michigan Society of Hematology and Oncology. Munson Healthcare is accredited by the Michigan State Medical Society to provide continuing medical education for physicians.
Munson Healthcare designates this live activity for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Click Here to Register Today!
Be sure to also register for Part 2 of this series on November 16!
A Virtual Event